User:Gmoren5/Opportunistic infections

Article Draft
Talk:

Hello, I am a fourth-year medical student participating in the WikiMed course at my university. I’m excited to be able to participate in this article and would welcome any suggestions or advice for my following edits. I am mainly focused on the prophylactic medication section. I want to add other infections we should be aware of when starting prophylactic medications. I also want to add more information on the indication sections, as CD4 count is not the only indication to start prophylactic medication. I want to add a new section discussing when it is appropriate to discontinue the medication. And finally, I want to update and add alternative medications when suggesting the agent.

Below is the bibliography, where I will be referring to the information. Thank you in advance for your suggestions and advice.

https://www.eacsociety.org/media/final2021eacsguidelinesv11.0_oct2021.pdf --> EU society guidelines for opportunistic infections, last updated in 2021

https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-oi/guidelines-adult-adolescent-oi.pdf --> CDC and NIH guidelines for opportunistic infections, updated regularly

https://www.ncbi.nlm.nih.gov/books/NBK567851/pdf/Bookshelf_NBK567851.pdf --> New York clinical guideline for HIV care, updated in 2021

Lead
Prophylactic medications

Individuals at higher risk are often prescribed prophylactic medication to prevent an infection from occurring. A person's risk level for developing an opportunistic infection is approximated using the person's CD4 T-cell count and other indications. The table below provides information regarding treatment management of common opportunistic infections.

Article body
Alternative agents can be used instead of the preferred agents. These alternative agents may be used due to allergies, availability, or clinical presentation. The alternative agents are listed in the table below.